Paranksy Noam
Known title: DirectorCIK: 0002022533
Paranksy Noam's purchase track record
How the stock did after each of Paranksy Noam's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since August 27, 2024
Stock higher 6 months later
100%
3 months: 100%
Median 6-month return
+174.2%
3 months: +85.4%
Beat the S&P 500
100%
median +168.3% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/12/2024 | TDUP | $32K | +84.1% | +160.0% | -1.3% |
| 9/4/2024 | TDUP | $245K | +85.4% | +174.2% | +5.8% |
| 8/27/2024 | TDUP | $72K | +91.9% | +219.4% | +5.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TDUP | ▲ Buy | Grant | 2,265 | $0 | 7/20/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 37,265 | $0 | 5/20/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 3,488 | $0 | 4/22/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 2,211 | $0 | 2/25/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 43,814 | $0 | 5/21/2025 | View on chart |
| TDUP | ▲ Buy | Grant | 11,077 | $0 | 12/30/2024 | View on chart |
| TDUP | ▲ Buy | Open Market | 20,008 | $16K | 9/12/2024 | View on chart |
| TDUP | ▲ Buy | Open Market | 20,000 | $16K | 9/12/2024 | View on chart |
| TDUP | ▲ Buy | Open Market | 40,000 | $31K | 9/6/2024 | View on chart |
| TDUP | ▲ Buy | Open Market | 80,000 | $68K | 9/5/2024 | View on chart |
| TDUP | ▲ Buy | Open Market | 180,000 | $146K | 9/4/2024 | View on chart |
| TDUP | ▲ Buy | Open Market | 90,000 | $72K | 8/27/2024 | View on chart |
| TDUP | ▲ Buy | Grant | 7,012 | $0 | 7/24/2024 | View on chart |
| TDUP | ▲ Buy | Grant | 149,432 | $0 | 6/23/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ThredUp Featured in Resale and GLP-1 Market Analysis
ThredUp was highlighted in recent articles discussing how resale and rental marketplaces are adapting to the GLP-1 weight-loss drug trend. One piece also listed the stock among growth opportunities to watch. These mentions focus on the company's position in the circular fashion economy rather than specific financial results.
ThredUp Featured in Resale and GLP-1 Market Analysis. ThredUp was highlighted in recent articles discussing how resale and rental marketplaces are adapting to the GLP-1 weight-loss drug trend. One piece also listed the stock among growth opportunities to watch. These mentions focus on the company's position in the circular fashion economy rather than specific financial results.